期刊文献+

治疗酶的研究进展 被引量:3

Progress in the research of therapeutic enzyme
原文传递
导出
摘要 随着生物技术和现代药剂学研究的进展,酶类药物的应用取得了快速发展,已成为生物药物的一个重要门类。以下对治疗用酶的新品种、作用机理和新技术在治疗酶中的应用、酶作为药物靶点的应用等进行了回顾,并对未来治疗酶的发展方向进行了讨论。 With the development of the research on biotechnology and modern pharmacy,the application of enzyme drugs have grown rapidly and enzyme drugs have become an important branch of biopharmaceutics.In this article,some new varieties of therapeutic enzymes,enzyme targets,mechanisms and new technologies of application in therapeutic enzymes were reviewed,and the direction of development of therapeutic enzymes were discussed.
出处 《生物工程学报》 CAS CSCD 北大核心 2009年第12期1852-1862,共11页 Chinese Journal of Biotechnology
关键词 治疗酶 新品种 作用机理 新技术 therapeutic enzyme new varieties mechanisms new technologies
  • 相关文献

参考文献39

  • 1Izzo F, Marra P, Beneduce G, et al. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J Clin Oncol, 2004, 22(10): 1815-1822.
  • 2Holtsberg FW, Ensor CM, Steiner MR, et al. Poly (ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties. J Control Rel, 2002, 80: 259-272.
  • 3Kruger K, Grabowski PJ, Zaug AJ, et al. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena. Cell, 1982, 31(1): 147-157.
  • 4Tokunaga T, Abe Y, Tsuchida T, et al. Ribozyme mediated cleavage of cell-associated isoform of vascular endothelial growth factor inhibits liver metastasis of a pancreatic cancer cell line. Int J Oncol, 2002, 21(5): 1027-1032.
  • 5Ciafre SA, Niola F, Wannenes E et al. An anti-VEGF ribozyme embedded within the adenoviral VAI sequence inhibits glioblastoma cell angiogenic potential in vitro. J Vasc Res, 2004, 41(3): 220-228.
  • 6Oshika Y, Nakamura M, Tokunaga T, et al. Ribozyme approach to down regulate vascular endothelial growth factor 189 expression in non-small cell lung cancer. Eur J Cancer, 2000, 36: 2390-2396.
  • 7Tokunaga T, Abe Y, Tsuchida T, et al. Ribozyme mediated cleavage of cell-associated isoform of vascular endothelial growth factor inhibits liver metastasis of a pancreatic cancer cell line.Int J Oncol, 2002, 21(5): 1027-1032.
  • 8Ciafre SA, Niola F, Wannenes F, et al. An anti-VEGF ribozyme embedded within the adenoviral VAI sequence inhibits glioblastoma cell angiogenic potential in vitro. J Vasc Res, 2004, 41(3): 220-228.
  • 9Kobayashi H, Eckhardt SG, Lockridge JA, et al. Safety and pharmacokinetic study of RPI. 4610(ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol, 2005, 56(4): 329-336.
  • 10Gibson SA, Pellenz C, Hutchison RE, et al. Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector. Clin Cancer Res, 2000, 6(1): 213-222.

二级参考文献162

共引文献56

同被引文献48

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部